[:fr]

Abstract

Antibody-mediated autoimmune diseases (AAID) involve several isotypes of autoreactive antibodies. In a growing number of AAID, autoreactive IgE are present with a significant prevalence and are often associated with the presence of IgG anti-IgE and/or anti-FcεRIα (high affinity IgE receptor α chain). FcεRI-bearing cells, such as basophils or mast cells, are key players in some of these AAID. Recent advances in the pathophysiology of these diseases led to the passed or current development of anti-IgE strategies that showed very potent effects in some of them. The present review centralizes the information on the relevance of autoreactive IgE and FcεRI-bearing cells in the pathophysiology of different AAID and the ones where the anti-IgE therapeutic strategy shows or may show some benefits for the patients.

[:]

Autres publications

Auteurs :
Tchen John,
Simon Quentin,
Chapart Lea,
Thaminy Morgane,
Vibhushan Shamila,
Saveanu Loredana,
Lamri Yasmine,
Saidoune Fanny,
Lebourdais-Pacreau Emeline,
Pellefigues Christophe,
Bex-Coudrat Julie,
Hajime KARASUYAMA,
Kensuke MIYAKE,
Juan HIDALGO,
Padraic G. FALLON,
Papo Thomas,
Blank Ulrich,
Benhamou Marc,
Hanouna Guillaume,
Sacre Karim,
Daugas Eric,
Nicolas Charles,
En savoir +
Auteurs :
Nicolas Charles,
Inge Kortekaas-Krohn,
Emek Kocaturk,
Jörg Scheffel,
Sabine Altrichter,
Carolin Steinert,
Yi-Kui Xiang,
Jan Gutermuth,
Laurent L Reber,
Marcus Maurer,
En savoir +
Auteurs :
Tchen John,
Simon Quentin,
Chapart Lea,
Lamri Yasmine,
Saidoune Fanny,
Lebourdais-Pacreau Emeline,
Pellefigues Christophe,
Bex-Coudrat Julie,
Karasuyama H,
Miyake K,
Hidalgo J,
Fallon PG,
Papo Thomas,
Blank Ulrich,
Benhamou Marc,
Hanouna Guillaume,
Sacre Karim,
Daugas Eric,
Nicolas Charles,
En savoir +
Auteurs :
Mageau Arthur,
Tchen John,
Valentine Marie Ferré,
Pascale Nicaise-Roland,
Diane Descamps,
Nicole Delory,
Chrystelle François,
Celine Mendes,
Papo Thomas,
Tiphaine Goulenok,
Nicolas Charles,
Sacre Karim,
En savoir +
Ce site est enregistré sur wpml.org en tant que site de développement. Passez à un site de production en utilisant la clé remove this banner.